STOCK TITAN

Labcorp Holdings (LH) Stock News

LH NYSE

Welcome to our dedicated page for Labcorp Holdings news (Ticker: LH), a resource for investors and traders seeking the latest updates and insights on Labcorp Holdings stock.

Labcorp Holdings Inc. provides laboratory services spanning diagnostics and drug development laboratory capabilities for doctors, hospitals, pharmaceutical companies, researchers and patients. News about LH commonly covers earnings releases and guidance, dividend declarations, specialty and companion diagnostics, oncology testing, drug-screening products, and collaborations that expand access to advanced laboratory services.

Company updates also address Labcorp's Diagnostics Laboratories and Biopharma Laboratory Services activities, including FDA-cleared or FDA-approved tests, pediatric diagnostics development, real-world data platforms, digital pathology and AI-enabled laboratory operations. Recurring announcements connect Labcorp's national diagnostic infrastructure with health systems, biopharmaceutical customers and technology partners.

Rhea-AI Summary

LabCorp (NYSE: LH) has entered a multi-year partnership with Infirmary Health, Alabama's largest non-governmental health care system, to provide laboratory services across the eastern Gulf Coast. This collaboration aims to enhance lab management, phlebotomy, and logistics, focusing on improving testing turnaround times and expanding COVID-19 testing capabilities. LabCorp will leverage its resources to support Infirmary Health's recent lab transformation efforts, bringing new instruments online and increasing lab staffing to elevate patient care quality in the region.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.3%
Tags
partnership
-
Rhea-AI Summary

LabCorp (NYSE: LH) will announce its third quarter 2020 financial results on October 27, 2020, before market opening. A conference call will follow at 9:00 a.m. EDT for discussion of results. Interested parties can join via phone or real-time webcast. The financial report and details will be available on the LabCorp Investor Relations website. The company, recognized as a leading global life sciences entity, reported revenues exceeding $11.5 billion in 2019.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.3%
Tags

FAQ

What is the current stock price of Labcorp Holdings (LH)?

The current stock price of Labcorp Holdings (LH) is $309.2 as of July 31, 2026.

What is the market cap of Labcorp Holdings (LH)?

The market cap of Labcorp Holdings (LH) is approximately 25.9B.